Prime Highlights
- DKSH Technology has signed an agreement to acquire Vietnam-based Biomedic, expanding its life sciences and healthcare footprint in the country.
- The acquisition supports DKSH’s regional growth strategy and strengthens its scientific solutions business in Vietnam’s fast-growing healthcare market.
Key Facts
- Founded in 2008, Biomedic operates from three locations in Vietnam, employs over 80 people, and generates nearly $15.25 million in annual net sales.
- The transaction is expected to close in the first quarter of 2026, subject to standard regulatory and closing conditions.
Background:
DKSH Technology has agreed to acquire Biomedic, a Vietnam-based distributor of healthcare and scientific solutions, strengthening its presence in the country’s life sciences and healthcare sector. The company announced the agreement on December 24 as part of its wider regional expansion strategy.
Established in Hanoi in 2008, Biomedic is a well-known player in Vietnam’s healthcare market. The company supplies testing, diagnostic and screening solutions used in areas such as oncology, obstetrics and gynaecology, infectious diseases and forensics. Biomedic serves hospitals, testing labs and fertility clinics across Vietnam.
The company’s equipment placement model helps generate steady income through consumable supplies. Biomedic has also built long-standing partnerships with leading global biotechnology and healthcare companies, giving it a strong and trusted position in Vietnam’s market.
Commenting on the transaction, Biomedic founder Cao Tien Dung said the company has spent nearly two decades connecting international biotechnology companies with customers across Vietnam. He described the agreement with DKSH as a natural next step that will support future growth while creating new opportunities for employees, partners and customers.
DKSH Business Unit Technology head Hanno Elbraechter said the group is pleased to join forces with Biomedic, noting its strong scientific workflow expertise and experienced sales, service and application teams operating across northern and southern Vietnam. He added that the partnership will allow DKSH to further strengthen its position in Vietnam’s expanding life sciences and healthcare sector.
The deal is expected to be completed in the first quarter of 2026, subject to standard closing conditions.
DKSH has been in operation for more than 160 years and runs its business across 36 markets globally. It operates in Healthcare, Consumer Goods, Performance Materials and Technology sectors. The company is listed on the SIX Swiss Exchange, employs over 28,000 people, and follows the United Nations Global Compact principles for responsible and sustainable business.
